Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, June 13, 2024 -- For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19 (PASC) reduce over three years but persist, especially among hospitalized individuals, according to a study published online May 30 in Nature Medicine.

Miao Cai, Ph.D., from the Veterans Affairs St. Louis Health Care System, and colleagues followed a cohort of 135,161 people with SARS-CoV-2 infection and 5,206,835 controls from the U.S. Department of Veterans Affairs who were followed for three years to estimate the risks for death and PASC.

The researchers found that the increased risk for death was no longer seen after the first year of infection among nonhospitalized individuals. The risk for incident PASC declined over three years, but in the third year, it still accounted for 9.6 disability-adjusted life years (DALYs) per 1,000 persons in year 3. The risk for death decreased among hospitalized individuals, but in the third year after infection, it remained significantly elevated (incidence rate ratio, 1.29). Over the three years, the risk for incident PASC decreased, but substantial residual risk persisted in the third year, resulting in 90.0 DALYs per 1,000 persons.

"That a mild SARS-CoV-2 infection can lead to new health problems three years down the road is a sobering finding," Ziyad Al-Aly, M.D., also from the Veterans Affairs St. Louis Health Care System, said in a statement. "The problem is even worse for people with severe SARS-CoV-2 infection. It is very concerning that the burden of disease among hospitalized individuals is astronomically higher."

Several authors disclosed ties to the pharmaceutical industry; one author reported ties to Guidepoint.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-14 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords